Thema
Journal Article
13
Randomized Controlled Trial
10
Clinical Trial, Phase III
7
Research Support, Non-U.S. Gov't
7
Multicenter Study
5
Risankizumab
5
90ZX3Q3FR7
4
Adalimumab
4
Antibodies, Monoclonal
4
FYS6T7F842
4
Hidradenitis suppurativa
4
Interleukin 23 inhibitor
4
risankizumab
4
Comparative Study
3
Anti-Inflammatory Agents
2
Bayesian hierarchical model
2
FU77B4U5Z0
2
IL23A protein, human
2
Interleukin-23 Subunit p19
2
Placebos
2
Ustekinumab
2
deep learning
2
family-wise error rate control
2
power preservation
2
prospective algorithm
2
sample size
2
187348-17-0
1
4RA0KN46E0
1
Adaptive design
1
Antibodies, Monoclonal, Humanized
1
Bonferroni test
1
Clinical Trial, Phase IV
1
DLQI
1
Dermatologic Agents
1
Dunnett test
1
Equivalence Trial
1
Heterocyclic Compounds, 3-Ring
1
Immunoglobulin G
1
Interleukin-12
1
Janus Kinase Inhibitors
1
NAPSI
1
NPPFS
1
PIONEERI
1
PIONEERII
1
Tumor Necrosis Factor Inhibitors
1
Tumor Necrosis Factor-alpha
1
abscess
1
adalimumab
1
autoinjector
1
closed testing procedure
1
mehr ...